Examining Brain-microbiome Communication in Neurodegeneration and Neuroinflammation

Gendelman Raad^*
*Correspondence: Gendelman Raad, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA, USA, Email:

Introduction

In recent years, the understanding of the intricate interplay between the gut microbiome and the brain has expanded dramatically. The gut-brain axis, a bidirectional communication system between the Central Nervous System (CNS) and the gastrointestinal tract, has emerged as a critical player in regulating various physiological and pathological processes. One particularly intriguing aspect of this communication is its impact on neurodegeneration and neuroinflammation. This article delves into the intricate relationship between the gut microbiome and the brain, focusing on how dysregulation in this communication pathway contributes to neurodegenerative diseases and neuroinflammation.

The gut microbiome, consisting of trillions of microorganisms inhabiting the gastrointestinal tract, plays a fundamental role in maintaining host homeostasis. These microorganisms participate in numerous physiological processes, including digestion, immune regulation, and neurotransmitter synthesis. Importantly, the gut microbiome communicates bidirectionally with the brain through various pathways, including the vagus nerve, immune system modulation, and production of microbial metabolites. Neurodegenerative diseases, such as Alzheimer's Disease (AD), Parkinson's Disease (PD), and Amyotrophic Lateral Sclerosis (ALS), are characterized by progressive loss of neuronal function and structure. Neuroinflammation, a common feature across these disorders, involves chronic activation of the brain's immune cells, leading to neuronal damage and dysfunction. Emerging evidence suggests that alterations in gut microbiota composition and function contribute to the pathogenesis of neurodegenerative diseases by promoting neuroinflammation and neuronal injury [1].

Neurodegeneration and neuroinflammation are critical processes that underlie a range of debilitating neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). These conditions, often characterized by the progressive loss of neuronal function and structure, represent a significant challenge to public health globally. While the exact mechanisms driving neurodegeneration remain incompletely understood, it is increasingly clear that neuroinflammation— an inflammatory response within the central nervous system (CNS)— plays a crucial role in both the onset and progression of these disorders. Neurodegeneration refers to the gradual and irreversible loss of neuronal cells and the connections between them, leading to impaired cognitive, motor, and sensory functions. This process is driven by a combination of genetic, environmental, and lifestyle factors, resulting in the accumulation of toxic proteins, oxidative stress, mitochondrial dysfunction, and disruptions in cellular homeostasis. As neurons are damaged, they can trigger an inflammatory response, a phenomenon known as neuroinflammation [2].

Description

Neuroinflammation, often driven by the activation of microglia (the resident immune cells of the brain) and astrocytes, is typically a protective response aimed at combating injury or infection. However, in the context of neurodegenerative diseases, chronic or excessive neuroinflammation can exacerbate neuronal damage, promote disease progression, and contribute to cognitive decline and motor dysfunction. This prolonged inflammatory state in the brain is thought to involve the release of pro-inflammatory cytokines, reactive oxygen species (ROS), and other harmful mediators, which may lead to further neuronal injury and synaptic dysfunction.

In recent years, the interplay between neurodegeneration and neuroinflammation has become a major area of focus in neuroscience research. Understanding how inflammation contributes to the progression of neurodegenerative diseases, and whether it represents a potential therapeutic target, has the potential to revolutionize the management of these devastating conditions. This review will explore the mechanisms of neurodegeneration and neuroinflammation, examining how the inflammatory response contributes to disease pathogenesis and highlighting emerging strategies to modulate neuroinflammation for therapeutic benefit in neurodegenerative disorders. The gut microbiome influences neuroinflammation through multiple mechanisms. Dysbiosis, characterized by imbalances in microbial composition and diversity, can trigger immune system dysregulation, leading to chronic inflammation within the CNS. Moreover, gut-derived microbial metabolites, such as Short- Chain Fatty Acids (SCFAs) and lipopolysaccharides (LPS), can translocate into the systemic circulation and activate microglia, the resident immune cells of the brain, exacerbating neuroinflammatory responses [3].

Mounting evidence suggests a link between gut dysbiosis and the onset and progression of neurodegenerative diseases. In AD, for instance, alterations in gut microbial composition correlate with disease severity and cognitive decline. Similarly, in PD, changes in gut microbiota composition precede motor symptoms, implicating a potential role of the gut-brain axis in disease pathogenesis. Moreover, experimental studies in animal models have demonstrated that manipulation of the gut microbiome can modulate disease progression, highlighting the therapeutic potential of targeting gut-brain communication in neurodegenerative disorders [4].

Harnessing the therapeutic potential of the gut-brain axis represents a promising avenue for the treatment of neurodegenerative diseases and neuroinflammation. Strategies aimed at restoring gut microbial homeostasis, such as probiotics, prebiotics, and fecal microbiota transplantation, have shown beneficial effects in preclinical models and clinical studies. Additionally, dietary interventions targeting the gut microbiome, such as the Mediterranean diet and ketogenic diet, have been associated with reduced neuroinflammation and improved cognitive function in neurodegenerative disease patients [5].

Conclusion

The intricate communication between the gut microbiome and the brain plays a crucial role in regulating neuroinflammation and neurodegeneration. Dysregulation of this axis contributes to the pathogenesis of various neurodegenerative diseases, highlighting its therapeutic potential as a target for intervention. Further research is needed to elucidate the underlying mechanisms governing gut-brain communication and to develop effective therapeutic strategies for combating neuroinflammation and neurodegeneration. By unraveling the mysteries of the gut-brain axis, we may unlock novel approaches for treating and preventing debilitating neurological disorders.

References

1. Jellinger, Kurt A. "Basic mechanisms of neurodegeneration: a critical update." J Cell Mol Med 14 (2010): 457-487.

Google Scholar, Crossref, Indexed at

2. Chen, Wei‑Wei, X. I. A. Zhang and Wen‑Juan Huang. "Role of neuroinflammation in neurodegenerative diseases." Mol Med Rep 13 (2016): 3391-3396.

Google Scholar, Crossref, Indexed at

3. Guzman-Martinez, Leonardo, Ricardo B. Maccioni, Víctor Andrade and Leonardo Patricio Navarrete, et al. "Neuroinflammation as a common feature of neurodegenerative disorders." Front Pharmacol 10 (2019): 1008.

Google Scholar, Crossref, Indexed at

4. Cryan, John F. and Timothy G. Dinan. "Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour." Nat Rev Neurosci 13 (2012): 701-712.

Google Scholar, Crossref, Indexed at

5. Fung, Thomas C., Christine A. Olson and Elaine Y. Hsiao. "Interactions between the microbiota, immune and nervous systems in health and disease." Nat Neurosci 20 (2017): 145-155.

Google Scholar, Crossref, Indexed at